Baird Financial Group’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,455
| Closed | -$260K | – | 1700 |
|
|
2023
Q1 | $260K | Sell |
11,455
-739
| -6% | -$16.8K | ﹤0.01% | 1534 |
|
|
2022
Q4 | $287K | Sell |
12,194
-155
| -1% | -$3.65K | ﹤0.01% | 1469 |
|
|
2022
Q3 | $322K | Sell |
12,349
-1,397
| -10% | -$36.4K | ﹤0.01% | 1437 |
|
|
2022
Q2 | $302K | Sell |
13,746
-603
| -4% | -$13.2K | ﹤0.01% | 1554 |
|
|
2022
Q1 | $644K | Buy |
14,349
+674
| +5% | +$30.3K | ﹤0.01% | 1315 |
|
|
2021
Q4 | $586K | Sell |
13,675
-366
| -3% | -$15.7K | ﹤0.01% | 1412 |
|
|
2021
Q3 | $934K | Buy |
14,041
+1,448
| +11% | +$96.3K | ﹤0.01% | 1226 |
|
|
2021
Q2 | $923K | Buy |
12,593
+230
| +2% | +$16.9K | ﹤0.01% | 1209 |
|
|
2021
Q1 | $846K | Buy |
12,363
+787
| +7% | +$53.9K | ﹤0.01% | 1186 |
|
|
2020
Q4 | $777K | Buy |
11,576
+1,884
| +19% | +$126K | ﹤0.01% | 1095 |
|
|
2020
Q3 | $499K | Buy |
+9,692
| New | +$499K | ﹤0.01% | 1152 |
|